APA (7th ed.) Citation

Cucciniello, L., Giudici, F., Di Nardo, P., Dri, A., Della Rossa, S., Zottarelli, E., . . . Puglisi, F. (2024). 380P Assessing interstitial lung disease (ILD) risk in metastatic breast cancer (MBC): A comprehensive meta and network analysis of antibody-drug conjugates (ADCs) compared to available treatment options beyond first-line (1L). Annals of Oncology, 35, S378. https://doi.org/10.1016/j.annonc.2024.08.328

Chicago Style (17th ed.) Citation

Cucciniello, L., et al. "380P Assessing Interstitial Lung Disease (ILD) Risk in Metastatic Breast Cancer (MBC): A Comprehensive Meta and Network Analysis of Antibody-drug Conjugates (ADCs) Compared to Available Treatment Options Beyond First-line (1L)." Annals of Oncology 35 (2024): S378. https://doi.org/10.1016/j.annonc.2024.08.328.

MLA (9th ed.) Citation

Cucciniello, L., et al. "380P Assessing Interstitial Lung Disease (ILD) Risk in Metastatic Breast Cancer (MBC): A Comprehensive Meta and Network Analysis of Antibody-drug Conjugates (ADCs) Compared to Available Treatment Options Beyond First-line (1L)." Annals of Oncology, vol. 35, 2024, p. S378, https://doi.org/10.1016/j.annonc.2024.08.328.